All Companies
ABBV
ABBVIE INC.Pharmaceutical Preparations
$263.96updated Sep 19, 2026
Congressional trading profile for ABBVIE INC. (ABBV), covering 37 disclosed transactions by 13 lawmakers.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Total Trades
37
Politicians Trading
13
Last Traded
Jun 2, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Jul 6, 2026 | Jun 2, 2026 | Buy | $1,001 - $15,000 | +22.54% |
| Ro KhannaD | Jun 9, 2026 | May 15, 2026 | Buy | $15,001 - $50,000 | +25.46% |
| Ro KhannaD | Jun 9, 2026 | May 1, 2026 | Buy | $15,001 - $50,000 | +27.76% |
| Josh GottheimerD | Jun 11, 2025 | May 22, 2025 | Buy | $1,001 - $15,000 | +44.60% |
| Josh GottheimerD | May 14, 2025 | Apr 3, 2025 | Buy | $1,001 - $15,000 | +30.91% |
| Josh GottheimerD | May 14, 2025 | Apr 1, 2025 | Buy | $1,001 - $15,000 | +27.97% |
| Jared MoskowitzD | May 9, 2025 | Apr 7, 2025 | Buy | $1,001 - $15,000 | +41.50% |
| Jared MoskowitzD | Feb 10, 2025 | Jan 15, 2025 | Buy | $1,001 - $15,000 | +54.05% |
| Jared MoskowitzD | Feb 10, 2025 | Jan 15, 2025 | Buy | $1,001 - $15,000 | +54.05% |